When Less Is More: An Avenue for Academia-Industry Collaboration in Pediatric Cancer

被引：0

作者：

Sasi, Archana ^{[1
]}

Bakhshi, Shikhar ^{[2
]}

Ganguly, Shuvadeep ^{[3
]}

机构：

[1] All India Inst Med Sci, Dept Med Oncol, Dr BRA Inst, Rotary Canc Hosp, New Delhi 110029, India

[2] CanKids KidsCan, Pediat Canc Res Inst, New Delhi, India

[3] Jawaharlal Inst Postgrad Med Educ & Res, Dept Med Oncol, Pondicherry, India

来源：

INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY | 2025年

关键词：

RANDOMIZED-TRIAL;

D O I：

10.1055/s-0044-1800795

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页数：3

共 15 条

[1] Cost-effectiveness research in cancer therapy: a systematic review of literature trends, methods and the influence of funding
Al-Badriyeh, Daoud
Alameri, Marwah
Al-Okka, Randa
[J]. BMJ OPEN, 2017, 7 (01):
[2] Sex Bias in Treatment Abandonment of Childhood Cancer in India
Bhatia, Kanu Priya
Ganguly, Shuvadeep
Sasi, Archana
Kumar, Vivek
Agarwala, Sandeep
Meel, Rachna
Khan, Shah Alam
Pushpam, Deepam
Bagai, Poonam
Sharma, Sonal
Ahamad, Nasim
Kumari, Mamta
Bakhshi, Sameer
[J]. INDIAN JOURNAL OF PEDIATRICS, 2024, 91 (11) : 1119 - 1126
[3] Bhatt Arun, 2019, Perspect Clin Res, V10, P103, DOI 10.4103/picr.PICR_103_19
[4] A pilot study of lower doses of ibrutinib in patients with chronic lymphocytic leukemia
Chen, Lisa S.
Bose, Prithviraj
Cruz, Nichole D.
Jiang, Yongying
Wu, Qi
Thompson, Philip A.
Feng, Shuju
Kroll, Michael H.
Qiao, Wei
Huang, Xuelin
Jain, Nitin
Wierda, William G.
Keating, Michael J.
Gandhi, Varsha
[J]. BLOOD, 2018, 132 (21) : 2249 - 2259
[5] A multicentre, randomised trial comparing schedules of G-CSF ( fi lgrastim) administration for primary prophylaxis of chemotherapy -induced febrile neutropenia in early stage breast cancer
Clemons, M.
Fergusson, D.
Simos, D.
Mates, M.
Robinson, A.
Califaretti, N.
Zibdawi, L.
Bahl, M.
Raphael, J.
Ibrahim, M. F. K.
Fernandes, R.
Pitre, L.
Aseyev, O.
Stober, C.
Vandermeer, L.
Saunders, D.
Hutton, B.
Mallick, R.
Pond, G. R.
Awan, A.
Hilton, J.
[J]. ANNALS OF ONCOLOGY, 2020, 31 (07) : 951 - 957
[6] The Critical Role of Academic Clinical Trials in Pediatric Cancer Drug Approvals: Design, Conduct, and Fit for Purpose Data for Positive Regulatory Decisions
De Wilde, Bram
Barry, Elly
Fox, Elizabeth
Karres, Dominik
Kieran, Mark
Manlay, John
Ludwinski, Donna
Reaman, Gregory
Kearns, Pamela
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (29) : 3456 - +
[7] 6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trial
Earl, Helena M.
Hiller, Louise
Vallier, Anne-Laure
Loi, Shrushma
McAdam, Karen
Hughes-Davies, Luke
Harnett, Adrian N.
Ah-See, Mei-Lin
Simcock, Richard
Rea, Daniel
Raj, Sanjay
Woodings, Pamela
Harries, Mark
Howe, Donna
Raynes, Kerry
Higgins, Helen B.
Wilcox, Maggie
Plummer, Chris
Mansi, Janine
Gounaris, Ioannis
Mahler-Araujo, Betania
Provenzano, Elena
Chhabra, Anita
Abraham, Jean E.
Caldas, Carlos
Hall, Peter S.
McCabe, Christopher
Hulme, Claire
Miles, David
Wardley, Andrew M.
Cameron, David A.
Dunn, Janet A.
[J]. LANCET, 2019, 393 (10191) : 2599 - 2612
[8] Childhood cancer in India
Ganguly, Shuvadeep
Kinsey, Sally
Bakhshi, Sameer
[J]. CANCER EPIDEMIOLOGY, 2021, 71
[9] High Cancer Drug Prices in the United States: Reasons and Proposed Solutions
Kantarjian, Hagop
Steensma, David
Sanjuan, Judit Rius
Elshaug, Adam
Light, Donald
[J]. JOURNAL OF ONCOLOGY PRACTICE, 2014, 10 (04) : E208 - E211
[10] Timing of first-in-child trials of FDA-approved oncology drugs
Neel, Dylan, V
Shulman, David S.
DuBois, Steven G.
[J]. EUROPEAN JOURNAL OF CANCER, 2019, 112 : 49 - 56

← 1 2 →